In this section, we review the myriad of recently published studies that relate the LDLR-independent effects of PCSK9 on vascular diseases that include atherosclerosis, myocardial infarction and calcification and discuss the assorted mechanisms by which PCSK9 targets the cardiovascular system (summarised in Figure 3). This evidence concerns the gene LDLR and atherosclerosis.